课题基金 / 基金详情

Creation of Transgenic Mice of Dialysis-Related Amyloidosis

Creation of Transgenic Mice of Dialysis-Related Amyloidosis
透析相关淀粉样变性转基因小鼠的创建
批准号:
10670990
负责人:
MARUYAMA Hiroki
金额:
$1.92万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1998
资助国家:
日本
项目状态:
已结题
起止时间:
1998 至 2000

项目摘要

项目成果

MARUYAMA Hiroki的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
To clarify the pathogenesis and establish therapy of dialysis-related amyloidosis, , we cloned humanβ_2-M cDNA by RT-PCR.We inserted humanβ_2-M cDNA into unique XhoI site of pCAGGS.We generated transgenic mice overexpressing humanβ_2-M (F0 5 lines). We confirmed humanβ_2-MmRNA by RT-PCR and northern blotting analysis, serum and urine humanβ_2-M by western blotting. We generated homozygote transgenic mice by mating F1. Serum humanβ_2-M levels (20-30mg/l)were as high as those levels in hemodialyzed patients. We could not observe dialysis-related amyloidosis in transgenic mice. These results demonstrated that only hyper β_2-M could not cause dialysis-related amyloidosis. We observe dialysis-related amyloidosis patients with chronic renal failure. To add a crucial factor, chronic renal failure, for development of dialysisrelated amyloidosis, we created five-sixths nephrectomized transgenic mice. We will analyze these mice.
期刊论文(30)
专著(0)
科研奖励(0)
会议论文
Hiroki Maruyama: "Requiring higher doses of erythropoietin suggests pregnancy in hemodialysis patients."Nephron. 79. 413-419 (1998)
Hiroki Maruyama:“需要更高剂量的促红细胞生成素表明血液透析患者怀孕。” 肾单位。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Hiroki Maruyama: "Pre-and postoperative management of patients with destructive spondyloarthropathy."Jpn.J.Clin.Dial.. 14. 83-89 (1998)
Hiroki Maruyama:“破坏性脊柱关节病患者的术前和术后管理。”Jpn.J.Clin.Dial.. 14. 83-89 (1998)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
Fumitake Gejyo: "The clinical effect of a β_2-microglobulin adsorption column of direct hemoperfusion Type [Lixelle] on dialysis-related-amyloidosis : A prospective multi-center controlled β_2-microglobulin adsorption column study (βMACS)"Kidney and Trans
Fumitake Gejyo:“直接血液灌流型 [Lixelle] β_2-微球蛋白吸附柱对透析相关淀粉样变性的临床效果:前瞻性多中心控制 β_2-微球蛋白吸附柱研究 (βMACS)” 肾脏和转运
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
丸山弘樹: "Annual review腎臓2001透析アミロイドーシスによる関節症の治療"中外医学社. 251 (2001)
Hiroki Maruyama:“2001 年肾透析淀粉样变性关节病治疗年度回顾”Chugai Igakusha 251 (2001)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
27
    Investigation of pathogenesis of Fabry nephropathy in novel model mouse
    • 批准号:
      23390223
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $10.48万
    • 财政年份:
      2011
    • 负责人:
      MARUYAMA Hiroki
    • 依托单位:
    Novel Mutations of the GLA Gene in Japanese Patients with Fabry disease and their functional characterization by active site specific chaperone
    • 批准号:
      18590884
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.57万
    • 财政年份:
      2006
    • 负责人:
      MARUYAMA Hiroki
    • 依托单位:
    Gene therapy for Fabry mice
    • 批准号:
      15590844
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.24万
    • 财政年份:
      2003
    • 负责人:
      MARUYAMA Hiroki
    • 依托单位:
    Kidney-targeted plasmid DNA transfer by retrograde renal vein injection
    • 批准号:
      13671103
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2001
    • 负责人:
      MARUYAMA Hiroki
    • 依托单位: